Abstract
Bronchiectasis is a chronic respiratory condition characterised by recurrent exacerbations and symptoms of a chronic cough, sputum production and shortness of breath. International guidelines recommend airway clearance techniques (ACTs)are taught to individuals with bronchiectasis to assist in clearing sputum, and that a change in technique may be required when an individual is unwell with an exacerbation. However, to date, there is limited evidence regarding relative effectiveness of types of ACTs during an exacerbation, despite these recommendations.The aims of this research were to 1. Identify the evidence available regarding the safety and effectiveness of ACTs for patients experiencing an acute exacerbation of bronchiectasis; 2. To identify and examine current Australian and New Zealand physiotherapy practice in the management of acute exacerbations of bronchiectasis, including the use of, perceived importance and effectiveness of ACTs, and identify factors that influence treatment decisions; 3. To compare the effects of three ACTs on sputum expectoration and health related quality of life (HRQOL), for adults hospitalised with an acute exacerbation of bronchiectasis; and 4. To explore the validity and responsiveness of a HRQOL questionnaire, the Bronchiectasis Health Questionnaire (BHQ), in assessing the HRQOL of individuals during an exacerbation of bronchiectasis.
A systematic review of the literature identified six studies, with small sample sizes, that investigated ACTs for individuals during an exacerbation of bronchiectasis. A variety of ACTs appeared safe to implement with adults, with no adverse events or deterioration of outcome measures following airway clearance therapy reported. Only one study reported significant differences between two ACTs; the active cycle of breathing technique (ACBT) with postural drainage was associated with greater improvements than percussion with postural drainage in cough-related quality of life, sputum expectoration and gas exchange. Most studies were underpowered to identify any clinically significant differences in treatment efficacy.
A survey establishing current practice among Australian and New Zealand physiotherapists for patients with acute exacerbations identified three ACTs commonly implemented, and also perceived effective, by all, or the vast majority, of respondents. These techniques were the ACBT, oscillating positive expiratory pressure (OPEP) therapy, walking with huffing.
A randomised controlled trial was subsequently completed to examine the effects of these three ACTs on sputum expectoration (wet weight), exercise capacity and HRQOL during an acute exacerbation requiring hospitalisation. No significant difference between the three ACTs in their effects on the primary outcome of 24-hoursputum expectoration, or in the percentage of 24-hour sputum that was expectorated during or in the hour following an ACT session were evident on day 2 of hospital admission or day of hospital discharge. Both walking with huffing and ACBT significantly improved in HRQOL at hospital discharge, while OPEP therapy demonstrated limited improvement. Walking with huffing had a greater improvement in cough-related quality of life compared to OPEP therapy, but no other between group differences were demonstrated.
The Bronchiectasis Health Questionnaire (BHQ) is a disease-specific questionnaire, designed to assess HRQOL for individuals with bronchiectasis, however it had not previously been validated during an acute exacerbation of bronchiectasis, or had its responsiveness to treatment explored. A validation study was conducted and found that, in individuals hospitalised with an acute exacerbation of bronchiectasis, the BHQ showed moderate-strong correlations with the Quality-of-life-Bronchiectasis Questionnaire and weak-moderate correlations with the Leicester Cough Questionnaire. There was an improvement in the mean BHQ score at hospital discharge, indicating that it is responsive to treatment.
The program of research reported in this thesis provides an important contribution to the current body of literature supporting the use of ACTs for adults with an acute exacerbation of bronchiectasis. All techniques appear to be safe to implement with adults during an acute exacerbation of bronchiectasis, with the ACBT, OPEP therapy and walking with huffing most commonly implemented. The randomised controlled trial included in this program of research is the first to explore walking with huffing as a standalone ACT for adults with an exacerbation of bronchiectasis, and demonstrated that there was no difference between this as an ACT and the ACBT and OPEP therapy in sputum expectoration over 24-hours, or in the percentage of24-hour sputum that was expectorated during or in the hour following the respective ACT session.
| Date of Award | 28 Nov 2024 |
|---|---|
| Original language | English |
| Supervisor | Wayne Hing (Supervisor), Rodney Pope (Supervisor) & Annemarie L. Lee (Supervisor) |
Cite this
- Standard